News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
61,001 Results
Type
Article (1840)
Company Profile (3)
Press Release (59158)
Section
Business (14953)
Career Advice (19)
Deals (2829)
Drug Delivery (2)
Drug Development (4516)
Employer Resources (2)
FDA (2936)
Job Trends (1003)
News (25913)
Policy (2247)
Tag
Academia (237)
Accelerated approval (3)
Adcomms (1)
Allergies (2)
Alliances (2974)
ALS (1)
Alzheimer's disease (13)
Antibody-drug conjugate (ADC) (5)
Approvals (3002)
Artificial intelligence (19)
Autoimmune disease (1)
Bankruptcy (23)
Best Places to Work (877)
Biosimilars (17)
Biotechnology (1)
Bladder cancer (37)
Brain cancer (15)
Breast cancer (52)
Cancer (400)
Cardiovascular disease (25)
Career advice (19)
CAR-T (3)
Cell therapy (24)
Cervical cancer (3)
Clinical research (4249)
Collaboration (76)
Compensation (25)
Complete response letters (2)
COVID-19 (39)
CRISPR (1)
C-suite (44)
Cystic fibrosis (2)
Data (455)
Depression (2)
Diabetes (30)
Diagnostics (353)
Digital health (6)
Drug discovery (3)
Earnings (7436)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (7643)
Executive appointments (64)
FDA (3336)
Frontotemporal dementia (1)
Funding (90)
Gene editing (1)
Gene therapy (40)
GLP-1 (21)
Government (198)
Guidances (45)
Healthcare (2490)
Huntington's disease (1)
Immunology and inflammation (2)
Immuno-oncology (2)
Indications (14)
Infectious disease (40)
Inflammatory bowel disease (6)
Intellectual property (12)
Interviews (1)
IPO (1122)
Job creations (145)
Job search strategy (19)
JPM (3)
Kidney cancer (1)
Labor market (1)
Layoffs (14)
Legal (420)
Liver cancer (18)
Longevity (1)
Lung cancer (46)
Lymphoma (7)
Machine learning (1)
Management (1)
Manufacturing (14)
MASH (1)
Medical device (4369)
Medtech (4390)
Mergers & acquisitions (1770)
Metabolic disorders (43)
Multiple sclerosis (1)
Neurodegenerative disease (8)
Neuropsychiatric disorders (4)
Neuroscience (76)
Neurotech (1)
NextGen: Class of 2026 (651)
Non-profit (259)
Now hiring (1)
Obesity (10)
Ovarian cancer (23)
Pain (54)
Pancreatic cancer (26)
Parkinson's disease (20)
Patents (26)
Patient recruitment (54)
People (4090)
Phase 1 (1084)
Phase 2 (1851)
Phase 3 (1611)
Pipeline (357)
Policy (1)
Postmarket research (168)
Preclinical (334)
Prostate cancer (27)
Radiopharmaceuticals (15)
Rare diseases (25)
Real estate (327)
Regulatory (2016)
Reports (4)
Research institute (152)
Schizophrenia (18)
Series A (8)
Series B (14)
Service/supplier (1)
Sickle cell disease (1)
Startups (226)
Supply chain (4)
Vaccines (12)
Venture capital (4)
Weight loss (4)
Women's health (14)
Date
Today (5)
Last 7 days (40)
Last 30 days (139)
Last 365 days (2081)
2026 (176)
2025 (2145)
2024 (2672)
2023 (3374)
2022 (6285)
2021 (5494)
2020 (4785)
2019 (4012)
2018 (3041)
2017 (3036)
2016 (2834)
2015 (3333)
2014 (2495)
2013 (2210)
2012 (2333)
2011 (2351)
2010 (2050)
Location
Africa (21)
Alabama (4)
Alaska (2)
Arizona (31)
Asia (2841)
Australia (399)
California (664)
Canada (153)
China (51)
Colorado (51)
Connecticut (56)
Delaware (13)
Europe (5629)
Florida (192)
Georgia (105)
Idaho (8)
Illinois (83)
India (3)
Indiana (51)
Iowa (1)
Japan (27)
Kansas (7)
Kentucky (1)
Louisiana (2)
Maryland (58)
Massachusetts (333)
Michigan (49)
Minnesota (101)
Mississippi (2)
Missouri (37)
Montana (11)
Nebraska (6)
Nevada (9)
New Hampshire (12)
New Jersey (252)
New Mexico (2)
New York (173)
North Carolina (142)
Northern California (301)
Ohio (48)
Oklahoma (2)
Oregon (8)
Pennsylvania (191)
Rhode Island (9)
South America (43)
South Carolina (4)
Southern California (259)
Tennessee (53)
Texas (152)
United States (2940)
Utah (24)
Virginia (19)
Washington State (20)
West Virginia (1)
Wisconsin (9)
61,001 Results for "onkos surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology
October 22, 2025
·
4 min read
Pharm Country
Onkos Surgical Presents at the Canaccord Genuity 2024 Musculoskeletal Healthcare Conference
Onkos Surgical presented Monday, February 12th at the Canaccord Genuity Musculoskeletal Conference in San Francisco.
February 13, 2024
·
4 min read
Pharm Country
Onkos Surgical to Present at Canaccord Genuity’s 2024 Musculoskeletal Conference
Onkos Surgical, Inc. announced today that it will present at Canaccord Genuity’s 2024 Musculoskeletal Conference in San Francisco, CA. Patrick Treacy, Onkos CEO and co-founder, is scheduled to present a corporate overview and update on February 12th, at the Westin St. Francis at 11:00 a.m. PST.
February 5, 2024
·
2 min read
BioCapital
MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants
MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) De Novo granting for Onkos Surgical’s antibacterial coating for tumor and revision orthopedic implants.
June 20, 2024
·
4 min read
Press Releases
Onkos Surgical® Successfully Completes Groundbreaking, First-in-Human Cases Using NanoCept™ Antibacterial Technology
January 9, 2025
·
4 min read
Pharm Country
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.
April 8, 2024
·
4 min read
Press Releases
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
January 8, 2025
·
4 min read
Press Releases
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
December 17, 2025
·
7 min read
Press Releases
Solventum Completes Acquisition of Acera Surgical
December 24, 2025
·
6 min read
Press Releases
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
February 2, 2026
·
3 min read
1 of 6,101
Next
